Combination therapy with multiple oral hypoglycaemic agents together with short-term basal insulin in new-onset Type 2 diabetes mellitus with marked hyperglycaemia

scientific article published on 6 June 2017

Combination therapy with multiple oral hypoglycaemic agents together with short-term basal insulin in new-onset Type 2 diabetes mellitus with marked hyperglycaemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/DME.13393
P698PubMed publication ID28586518

P50authorSubir RayQ96249441
P2093author name stringJ J Mukherjee
P2860cites workShort-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and β-cell function in subjects with long-term remissionQ35123342
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitusQ37141727
8. Pharmacologic Approaches to Glycemic TreatmentQ39040121
Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.Q39648063
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.Q47773960
P433issue9
P921main subjecthyperglycemiaQ271993
type 2 diabetesQ3025883
P304page(s)1322-1323
P577publication date2017-06-06
P1433published inDiabetic MedicineQ15758639
P1476titleCombination therapy with multiple oral hypoglycaemic agents together with short-term basal insulin in new-onset Type 2 diabetes mellitus with marked hyperglycaemia
P478volume34

Search more.